Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Study of Resveratrol on Drug and Carcinogen Metabolizing Enzymes

Trial Profile

Clinical Study of Resveratrol on Drug and Carcinogen Metabolizing Enzymes

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2014

At a glance

  • Drugs Resveratrol (Primary)
  • Indications Cancer metastases; Colorectal cancer; Multiple myeloma; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Sep 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov
    • 18 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 03 Dec 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top